What does CUSIP 514766104 represent in this 13F holders report?

CUSIP 514766104 is the security identifier for LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock used to aggregate holder disclosures.

How many institutions held LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock in Q2 2021?

95 institutional investors reported LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

CUSIP: 514766104

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 37,253,000
Total 13F shares: 25,595,693
Share change: -583,035
Total reported value: $287,942,521
Price per share: $11.25
Number of holders: 95
Value change: -$5,835,307
Number of buys: 46
Number of sells: 47

Quarterly Holders Quick Answers

What is CUSIP 514766104?
CUSIP 514766104 identifies LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 514766104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Legion Partners Asset Management, LLC	13F	Company	7.9%	2,928,090	$31,038,000	—	31 Mar 2021	13F
WYNNEFIELD CAPITAL INC	13F	Company	7.8%	2,905,300	$30,651,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	5.9%	2,183,158	$23,143,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	5.7%	2,136,480	$22,711,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	4.5%	1,679,164	$17,799,000	—	31 Mar 2021	13F
Cove Street Capital, LLC	13F	Company	4.5%	1,679,138	$17,798,000	—	31 Mar 2021	13F
HEARTLAND ADVISORS INC	13F	Company	3.3%	1,232,190	$13,061,000	—	31 Mar 2021	13F
Russell Investments Group, Ltd.	13F	Company	3.2%	1,180,729	$12,513,000	—	31 Mar 2021	13F
INVESTMENT COUNSELORS OF MARYLAND LLC	13F	Company	3.1%	1,139,877	$12,083,000	—	31 Mar 2021	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	3%	1,118,858	$11,860,000	—	31 Mar 2021	13F
Pacific Ridge Capital Partners, LLC	13F	Company	1.5%	566,561	$6,006,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	1.3%	487,224	$5,165,000	—	31 Mar 2021	13F
Visionary Wealth Advisors	13F	Company	1.3%	476,875	$5,055,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	422,960	$4,483,000	—	31 Mar 2021	13F
Walthausen & Co., LLC	13F	Company	1.1%	416,687	$4,417,000	—	31 Mar 2021	13F
AltraVue Capital, LLC	13F	Company	1%	383,592	$4,066,000	—	31 Mar 2021	13F
JOHN G ULLMAN & ASSOCIATES INC	13F	Company	0.99%	367,171	$3,892,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.8%	298,651	$3,166,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.75%	278,756	$2,955,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.6%	225,344	$2,389,000	—	31 Mar 2021	13F
Acuitas Investments, LLC	13F	Company	0.58%	217,717	$2,308,000	—	31 Mar 2021	13F
Boston Partners	13F	Company	0.54%	201,629	$2,138,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.46%	172,838	$1,833,000	—	31 Mar 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.45%	166,409	$1,764,000	—	31 Mar 2021	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	0.43%	159,498	$1,691,000	—	31 Mar 2021	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.43%	158,700	$1,682,000	—	31 Mar 2021	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.42%	155,800	$1,651,000	—	31 Mar 2021	13F
HARBERT FUND ADVISORS, INC.	13F	Company	0.41%	152,505	$1,617,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.4%	150,050	$1,590,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.39%	144,435	$1,531,000	—	31 Mar 2021	13F
IQ EQ FUND MANAGEMENT (IRELAND) Ltd	13F	Company	0.34%	127,583	$1,352,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.31%	116,562	$1,236,000	—	31 Mar 2021	13F
Legato Capital Management LLC	13F	Company	0.25%	94,407	$1,001,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.24%	91,090	$966,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.24%	91,087	$966,000	—	31 Mar 2021	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.23%	84,143	$892,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.22%	82,903	$878,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.21%	79,247	$840,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.21%	76,921	$815,000	—	31 Mar 2021	13F
ROYCE & ASSOCIATES LP	13F	Company	0.2%	75,610	$801,000	—	31 Mar 2021	13F
Ancora Advisors LLC	13F	Company	0.17%	64,244	$681,000	—	31 Mar 2021	13F
PERRITT CAPITAL MANAGEMENT INC	13F	Company	0.17%	63,100	$669,000	—	31 Mar 2021	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.17%	61,481	$652,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.16%	60,628	$643,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.16%	59,900	$635,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	0.16%	59,386	$630,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.14%	53,486	$567,000	—	31 Mar 2021	13F
OPPENHEIMER ASSET MANAGEMENT INC.	13F	Company	0.13%	46,783	$496,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.12%	45,889	$486,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0.12%	44,856	$475,000	—	31 Mar 2021	13F

Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2021

As of 30 Jun 2021, LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,595,693 shares. The largest 10 holders included WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, Cove Street Capital, LLC, VANGUARD GROUP INC, INVESTMENT COUNSELORS OF MARYLAND LLC, HEARTLAND ADVISORS INC, KENNEDY CAPITAL MANAGEMENT, INC., and Russell Investments Group, Ltd.. This page lists 95 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.